| Title : Blockade of Ca2+ -activated K+ channels by galantamine can also contribute to the potentiation of catecholamine secretion from chromaffin cells - Ales_2006_Eur.J.Pharmacol_548_45 |
| Author(s) : Ales E , Gullo F , Arias E , Olivares R , Garcia AG , Wanke E , Lopez MG |
| Ref : European Journal of Pharmacology , 548 :45 , 2006 |
| Abstract : |
| PubMedSearch : Ales_2006_Eur.J.Pharmacol_548_45 |
| PubMedID: 16949070 |
| Title : Can cholinesterase inhibitors provide additional effects to cholinergic neurotransmission enhancement? - Lopez_2006_J.Mol.Neurosci_30_141 |
| Author(s) : Lopez MG , Arias E , Sobrado M , Lorrio S , Roda JM , Garcia AG |
| Ref : Journal of Molecular Neuroscience , 30 :141 , 2006 |
| Abstract : |
| PubMedSearch : Lopez_2006_J.Mol.Neurosci_30_141 |
| PubMedID: 17192661 |
| Title : Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors - Arias_2005_J.Pharmacol.Exp.Ther_315_1346 |
| Author(s) : Arias E , Gallego-Sandin S , Villarroya M , Garcia AG , Lopez MG |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 315 :1346 , 2005 |
| Abstract : |
| PubMedSearch : Arias_2005_J.Pharmacol.Exp.Ther_315_1346 |
| PubMedID: 16144975 |
| Title : Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors - Arias_2004_Neuropharmacol_46_103 |
| Author(s) : Arias E , Ales E , Gabilan NH , Cano-Abad MF , Villarroya M , Garcia AG , Lopez MG |
| Ref : Neuropharmacology , 46 :103 , 2004 |
| Abstract : |
| PubMedSearch : Arias_2004_Neuropharmacol_46_103 |
| PubMedID: 14654102 |
| Title : ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylat e), a novel acetylcholinesterase inhibitor with calcium promotor and neuroprotective properties - Orozco_2004_J.Pharmacol.Exp.Ther_310_987 |
| Author(s) : Orozco C , de los Rios C , Arias E , Leon R , Garcia AG , Marco JL , Villarroya M , Lopez MG |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 310 :987 , 2004 |
| Abstract : |
| PubMedSearch : Orozco_2004_J.Pharmacol.Exp.Ther_310_987 |
| PubMedID: 15111641 |